Proposed Data Collection Submitted for Public Comment and Recommendations, 49374-49375 [2020-17710]
Download as PDF
<![CDATA[
49374
Federal Register / Vol. 85, No. 157 / Thursday, August 13, 2020 / Notices
requested for this information collection
total 185, which is a decrease of 737
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name/CFR reference
Nonhuman Primate Importer ..
CDC 75.10A Application for Registration as an Importer of
Nonhuman Primates (New Importer).
CDC 75.10A Application for Registration as an Importer of
Nonhuman Primates (Re-Registration).
71.53(g1)(iii) and (h) Documentation and Standard Operating Procedures (no form) (New Importer).
71.53(g)(1)(iii) and (h) Documentation and Standard Operating Procedures (no form) (Registered Importer).
Recordkeeping and reporting requirements for importing
NHPs: Notification of shipment arrival 71.53(k), (n) (no
form).
Statements regarding the health of the nonhuman primates
during travel and CDC quarantine (42 CFR 71.53(m) (no
form).
Statements, including necropsy reports, about the
nonhuman primates upon their release from CDC quarantine. (42 CFR 71.53(m) (no form).
Quarantine release 71.53(l) (no form) ...................................
71.53(v) Form: Filovirus Diagnostic Specimen Submission
Form for Non-human Primate Materials.
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Nonhuman Primate Importer ..
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–17709 Filed 8–12–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–1054; Docket No. CDC–2020–
0090]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Drug Overdose
Response Investigation (DORI) Data
Collections.’’ CDC will use the
SUMMARY:
VerDate Sep<11>2014
17:16 Aug 12, 2020
Jkt 250001
information collected to respond to
urgent requests from state and local
health authorities to provide
epidemiological information that allows
for the selection of interventions to curb
local epidemics of drug overdose.
DATES: Written comments must be
received on or before October 13, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0090 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Number of
respondents
Type of respondent
Average
burden per
response
(in hours)
1
1
10/60
12
1
10/60
1
1
10
12
1
30/60
25
6
15/60
25
6
15/60
25
3
15/60
25
10
6
10
15/60
20/60
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\13AUN1.SGM
13AUN1
49375
Federal Register / Vol. 85, No. 157 / Thursday, August 13, 2020 / Notices
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
Drug Overdose Response Investigation
(DORI) Data Collections (OMB Control
No. 0920–1054, Exp. 03/31/2018)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received OMB approval
(OMB Control No. 0920–1054) for a new
Generic clearance for a three-year period
to collect information to respond to
urgent requests from state and local
health authorities to provide
epidemiological information that allows
for the selection of interventions to curb
local epidemics of drug overdose. CDC
seeks OMB approval for a Revision of
this generic clearance for a three-year
period.
Drug Overdose Response Investigation
(DORI) are to be conducted in response
to urgent requests from state and local
health authorities. Of particular interest
is response to increasing trends in, or
changing characteristics of, overdose
from prescription drugs (with a special
interest in opioid analgesics such as
oxycodone or methadone;
benzodiazepines such as alprazolam)
and/or illicit drugs (e.g., heroin). CDC’s
National Center for Injury Prevention
and Control (NCIPC) is frequently called
upon to conduct DORIs at the request of
state or local health authorities seeking
support to respond to urgent public
health problems resulting from drug
use, misuse, addiction, and overdose.
Such requests are typically, but not
always, made through the Epi-Aid
mechanism. In most investigations,
CDC’s epidemiological response entails
rapid and flexible collection of data that
evolves during the investigation period.
A Generic clearance is requested to
ensure that timely information is
collected during a DORI, which allows
NCIPC to maintain critical mission
function by working with state and local
health authorities to protect the public’s
health. During an unanticipated rise in
nonfatal or fatal drug overdose where
the substances responsible for the health
event need to be identified, drivers and
risk factors are undetermined, and/or
subgroups at risk need to be identified,
immediate action by CDC is necessary to
minimize or prevent public harm. CDC
must have the ability to rapidly deploy
data collection tools to understand the
scope of the problem and determine
appropriate action. Procedures for each
investigation, including specific data
collection plans, depend on the time
and resources available, number of
persons involved, and other
circumstances unique to the urgent
conditions at hand. Data are collected
by epidemiologists, psychologists,
medical professionals, subject matter
experts, and biostatisticians.
Data collected during a DORI are used
to understand sudden increases in drug
use and misuse associated with fatal
and nonfatal overdoses, understand the
drivers and risk factors associated with
those trends, and identify the groups
most affected. This allows CDC to
effectively advise states on actions that
could be taken to control the local
epidemic. During a DORI, data are
collected once, with the rare need for
follow-up. The estimated annual burden
hours are 1,500, there are no costs to
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Drug Overdose Response Investigation Participants.
DORI Data Collection Instruments ...
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–17710 Filed 8–12–20; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10390]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
SUMMARY:
VerDate Sep<11>2014
17:16 Aug 12, 2020
Jkt 250001
3,000
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
30/60
Total
burden
hours
1,500
Comments must be received by
October 13, 2020.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
DATES:
E:\FR\FM\13AUN1.SGM
13AUN1
]]>Agencies
[Federal Register Volume 85, Number 157 (Thursday, August 13, 2020)]
[Notices]
[Pages 49374-49375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17710]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-1054; Docket No. CDC-2020-0090]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection entitled ``Drug Overdose Response Investigation
(DORI) Data Collections.'' CDC will use the information collected to
respond to urgent requests from state and local health authorities to
provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose.
DATES: Written comments must be received on or before October 13, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0090 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the
[[Page 49375]]
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology, e.g., permitting electronic submissions of responses.
5. Assess information collection costs.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections (OMB
Control No. 0920-1054, Exp. 03/31/2018)--Revision--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received OMB approval (OMB Control No. 0920-1054) for
a new Generic clearance for a three-year period to collect information
to respond to urgent requests from state and local health authorities
to provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. CDC seeks OMB
approval for a Revision of this generic clearance for a three-year
period.
Drug Overdose Response Investigation (DORI) are to be conducted in
response to urgent requests from state and local health authorities. Of
particular interest is response to increasing trends in, or changing
characteristics of, overdose from prescription drugs (with a special
interest in opioid analgesics such as oxycodone or methadone;
benzodiazepines such as alprazolam) and/or illicit drugs (e.g.,
heroin). CDC's National Center for Injury Prevention and Control
(NCIPC) is frequently called upon to conduct DORIs at the request of
state or local health authorities seeking support to respond to urgent
public health problems resulting from drug use, misuse, addiction, and
overdose. Such requests are typically, but not always, made through the
Epi-Aid mechanism. In most investigations, CDC's epidemiological
response entails rapid and flexible collection of data that evolves
during the investigation period.
A Generic clearance is requested to ensure that timely information
is collected during a DORI, which allows NCIPC to maintain critical
mission function by working with state and local health authorities to
protect the public's health. During an unanticipated rise in nonfatal
or fatal drug overdose where the substances responsible for the health
event need to be identified, drivers and risk factors are undetermined,
and/or subgroups at risk need to be identified, immediate action by CDC
is necessary to minimize or prevent public harm. CDC must have the
ability to rapidly deploy data collection tools to understand the scope
of the problem and determine appropriate action. Procedures for each
investigation, including specific data collection plans, depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand. Data are
collected by epidemiologists, psychologists, medical professionals,
subject matter experts, and biostatisticians.
Data collected during a DORI are used to understand sudden
increases in drug use and misuse associated with fatal and nonfatal
overdoses, understand the drivers and risk factors associated with
those trends, and identify the groups most affected. This allows CDC to
effectively advise states on actions that could be taken to control the
local epidemic. During a DORI, data are collected once, with the rare
need for follow-up. The estimated annual burden hours are 1,500, there
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response DORI Data 3,000 1 30/60 1,500
Investigation Participants. Collection
Instruments.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-17710 Filed 8-12-20; 8:45 am]
BILLING CODE 4163-19-P
